Bank of America’s RAPT Therapeutics RAPT Stock Holding History

Bank of America’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,675	Closed	-$192K	–	8388
2024 Q1	$192K	Buy	+2,675	New	+$372K	﹤0.01%	5901

Bank of America's RAPT Position: Q1 2026 in Review

Bank of America sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 58,330 shares — an estimated $1.98M sold.

Bank of America first reported a position in RAPT in Q4 2019 and held it in 25 quarters. The position peaked at $3.02M in Q4 2021. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

Bank of America reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
Bank of America sold 58,330 RAPT Therapeutics shares in Q1 2026, an estimated $1.98M.
Bank of America first reported a position in RAPT Therapeutics in Q4 2019 and held it in 25 quarters.
Bank of America's RAPT Therapeutics position peaked at $3.02M in Q4 2021.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.